Solventum Corporation (FRA:KB7)

Market Cap	12.77B
Revenue (ttm)	7.16B
Net Income (ttm)	1.30B
Shares Out	n/a
EPS (ttm)	7.43
PE Ratio	9.83
Forward PE	13.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Average Volume	140
Open	68.00
Previous Close	70.00
Day's Range	68.00 - 72.00
52-Week Range	54.40 - 80.50
Beta	n/a
RSI	68.62
Earnings Date	Nov 6, 2025

About Solventum

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical e...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Employees: 22,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KB7

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.

Financial numbers in USD